IHWM
ZYNE

Iron Horse Wealth Management’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History

Iron Horse Wealth Management’s Portfolio ZYNE Stock Details ZYNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-1
Closed -$1 – 526
2023
Q3 		$1 Hold
1
– – ﹤0.01% 507
2023
Q2 		$0 Hold
1
– – ﹤0.01% 359
2023
Q1 		$0 Hold
1
– – ﹤0.01% 380
2022
Q4 		$0 Hold
1
– – ﹤0.01% 286
2022
Q3 		$0 Hold
1
– – ﹤0.01% 311
2022
Q2 		$0 Hold
1
– – ﹤0.01% 333
2022
Q1 		$0 Hold
1
– – ﹤0.01% 274
2021
Q4 		$0 Hold
1
– – ﹤0.01% 254
2021
Q3 		$0 Buy
+1
New +$4 ﹤0.01% 243

Iron Horse Wealth Management's ZYNE Position: Q4 2023 in Review

Iron Horse Wealth Management sold out of Zynerba Pharmaceuticals, Inc (ZYNE) in Q4 2023, closing a stake of 1 share — an estimated $1 sold.

Iron Horse Wealth Management first reported a position in ZYNE in Q3 2021 and held it in 9 quarters. The position peaked at $1 in Q3 2023. 0 funds tracked by Wall St. Rank hold ZYNE as of Q4 2023.

  • Iron Horse Wealth Management reported no remaining Zynerba Pharmaceuticals, Inc position as of Q4 2023 after selling out during the quarter.
  • Iron Horse Wealth Management sold 1 Zynerba Pharmaceuticals, Inc share in Q4 2023, an estimated $1.
  • Iron Horse Wealth Management first reported a position in Zynerba Pharmaceuticals, Inc in Q3 2021 and held it in 9 quarters.
  • Iron Horse Wealth Management's Zynerba Pharmaceuticals, Inc position peaked at $1 in Q3 2023.
  • 0 funds tracked by Wall St. Rank held Zynerba Pharmaceuticals, Inc as of Q4 2023.

Based on Iron Horse Wealth Management's 13F filing for Q4 2023, filed 22 Jan 2024.